Mary Liu

Mary Liu is an experienced professional in regulatory affairs, currently serving as the Executive Director of Regulatory Affairs at ALX Oncology since January 2023. Prior to this role, Mary Liu worked at Exelixis as Senior Director and Director of Regulatory Affairs from January 2019 to December 2022. At Genentech, from April 2012 to January 2019, Mary Liu held positions including Associate Program Director and Associate Director of Regulatory Policy and Intelligence, contributing to areas such as oncology, respiratory diseases, and immunology. Earlier experience includes a post-doctoral fellowship in Regulatory Policy and Intelligence at Roche, focusing on regulatory strategy for various product categories, and an internship as a pharmacist at the Department of Veterans Affairs. Educational qualifications include a BA in Molecular and Cell Biology from the University of California, Berkeley, and a PharmD in Pharmacy from the University of Michigan.